Baxter International Inc. (BAX)
Health Care1 article
Price chart
Why is BAX moving today?
-1.9%BAX is -1.9% today, inside the ordinary range for a session (under 3%). No stories about it reached the feed in the last 24 hours.
What this does not prove. A story on the same day is evidence of timing, not of cause: it explains a move only if it accounts for the size and the direction, and most single-stock moves carry a sector or index component too. Nothing here is a forecast.
Source: Yahoo Finance - quote as of 2 days ago
Baxter International Inc. (BAX) overview
Baxter International makes hospital and renal-care medical products.
BAX is a member of the S&P 500. It sits in the Health Care sector. That sector covers pharmaceutical, biotech, device and managed-care companies.
Baxter International Inc. trades on the NYSE under the ticker symbol BAX. The most recent market data puts the share price at about $25.28. That is down 1.86% on the session. At that price the company is worth roughly $13.07B.
Over the past 52 weeks, BAX has traded between $15.73 and $30.00. BAX also pays a dividend. It yields around 0.16% at the current price.
Key statistics
Source: Yahoo Finance - quote as of 2 days ago
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Why investors watch BAX
BAX is one of the larger names in the Health Care sector, so investors follow it closely. It tends to move with the rest of the sector. This page sums up each BAX story as it breaks, and tags it bullish, bearish or neutral.
What moves BAX
- Earnings. BAX reports results four times a year. A surprise against the estimate tends to move the stock that day.
- Analyst calls. Upgrades, downgrades and new price targets change what the market expects from BAX.
- Sector news. Health Care stocks often move together, so a rival's news can move BAX too.
Market Mood
Latest BAX news
AbbVie (ABBV) Reports 2.8% Yield; Baxter (BAX) Cuts Dividend
AbbVie (ABBV) announced a quarterly dividend of $1.73 with a yield of 2.8%, extending its streak of increases since 2013. In contrast, Baxter (BAX) eliminated its dividend, reporting a net income loss of $900 million for FY2025, which disqualifies it from income-focused portfolios. AbbVie's revenue growth from Skyrizi and Rinvoq, at 31% and 23%, respectively, has helped offset losses from Humira and raised guidance for the year. The contrast between the two companies highlights the risks and potential for investors focused on income reliability and growth.
Read More: AbbVie (ABBV) Reports 2.8% Yield; Baxter (BAX) Cuts DividendMore Health Care stocks
Frequently asked questions
Is Baxter International Inc. in the S&P 500?
Yes. Baxter International Inc. trades as BAX and is a member of the S&P 500. The index lists it in the Health Care sector.
What sector is BAX in?
BAX sits in the Health Care sector of the S&P 500.
Where can I find the latest BAX news?
Right here. This page collects recent BAX news and market analysis. Every story gets an AI summary and a bullish, bearish or neutral tag.
What is Baxter International Inc.'s stock price?
BAX last traded at about $25.28. Prices move all through the session, so this is the latest quote rather than a live one.
What is Baxter International Inc.'s market cap?
BAX is worth roughly $13.07B. Market cap is the share price times the number of shares outstanding.